Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PROSTVAC-V/F TRICOM and GM-CSF in Prostate Cancer
NCT00108732Phase 2Completed
- Sponsor
- National Cancer Institute
- Start
- Feb 2006
- Primary completion
- Oct 2010
- Countries
- 1
01
Overview
A Phase 2 trial of rilimogene galvacirepvec in prostate cancer (PCa), sponsored by National Cancer Institute. Started Feb 2006; status: completed.
02
Drugs
rilimogene galvacirepvec
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00108732.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00108732.